Prostatitis classification

Jump to: navigation, search
Urinary Tract Infections Main Page

Prostatitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Prostatitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT scan

Echocardiography and Ultrasound

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Prostatitis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Prostatitis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Prostatitis classification

CDC on Prostatitis classification

Prostatitis classification in the news

Blogs on Prostatitis classification

Directions to Hospitals Treating Prostatitis

Risk calculators and risk factors for Prostatitis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D., Usama Talib, BSc, MD [2]

Overview

Prostatitis has been classified by International Prostatitis Collaboration Network, into 5 subtypes. This classification is done on the basis of timing of the symptoms and the presence of bacterial pathogens and other markers of infection and inflammation. The categories include acute bacterial prostatitis, chronic bacterial prostatitis, inflammatory chronic prostatitis/chronic pelvic pain syndrome, non-inflammatory chronic prostatitis/chronic pelvic pain syndrome, and asymptomatic inflammatory prostatitis.[1][2]

Classification

Prostatitis has been classified by International Prostatitis Collaboration Network, into 5 subtypes. This classification is done on the basis of timing of the symptoms and the presence of bacterial pathogens and other markers of infection and inflammation. The categories include:[1]


 
 
 
 
 
 
 
 
Prostatitis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acute bacterial prostatitis
 
Chronic bacterial prostatitis
 
Inflammatory chronic prostatitis/chronic pelvic pain syndrome
 
Non-inflammatory chronic prostatitis/chronic pelvic pain syndrome
 
Asymptomatic inflammatory prostatitis
 
 
 
 
 
 


  • Acute bacterial prostatitis: Acute symptoms with evidence of bacterial infection.[3]
  • Chronic bacterial prostatitis: Chronic symptoms with evidence of bacterial infection.[6]
  • Inflammatory chronic prostatitis/chronic pelvic pain syndrome: Chronic symptoms with inflammation but without any evidence of bacterial infection.[7]
  • Non-inflammatory chronic prostatitis/chronic pelvic pain syndrome: Chronic symptoms with neither inflammation nor evidence of bacterial infection.[12]
  • Asymptomatic inflammatory prostatitis: No symptoms with evidence of inflammation (incidental finding).[13]

References

  1. 1.0 1.1 Krieger JN, Nyberg L, Nickel JC (1999). "NIH consensus definition and classification of prostatitis". JAMA. 282 (3): 236–7. PMID 10422990.
  2. Yorio Naide, Kiyohito Ishikawa, Toshiyuki Tanaka, Shin Ando, Keizo Suzuki & Kiyotaka Hoshinaga (2006). "A proposal of subcategorization of bacterial prostatitis: NIH category I and II diseases can be further subcategorized on analysis by therapeutic and immunological procedures". International journal of urology : official journal of the Japanese Urological Association. 13 (7): 939–946. doi:10.1111/j.1442-2042.2006.01444.x. PMID 16882059. Unknown parameter |month= ignored (help)
  3. Gabriel Stoica, Gerard Cariou, Alexandre Colau, Ariane Cortesse, Patrice Hoffmann, Antoine Schaetz & Raphael Sellam (2007). "[Epidemiology and treatment of acute prostatitis after prostatic biopsy]". Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 17 (5): 960–963. PMID 17969797. Unknown parameter |month= ignored (help)
  4. Hsun-Shuan Wang & Ming-Chen Shih (2016). "IMAGES IN CLINICAL MEDICINE. Emphysematous Prostatitis". The New England journal of medicine. 375 (9): 879. doi:10.1056/NEJMicm1507124. PMID 27579638. Unknown parameter |month= ignored (help)
  5. Daniel A. Thorner, John P. Sfakianos, Fernando Cabrera, Erich K. Lang & Ivan Colon (2010). "Emphysematous prostatitis in a diabetic patient". The Journal of urology. 183 (5): 2025. doi:10.1016/j.juro.2010.01.084. PMID 20303525. Unknown parameter |month= ignored (help)
  6. James D. Holt, W. Allan Garrett, Tyler K. McCurry & Joel M. H. Teichman (2016). "Common Questions About Chronic Prostatitis". American family physician. 93 (4): 290–296. PMID 26926816. Unknown parameter |month= ignored (help)
  7. Anthony J. Schaeffer, Nand S. Datta, Jackson E. Jr Fowler, John N. Krieger, Mark S. Litwin, Robert B. Nadler, J. Curtis Nickel, Michel A. Pontari, Daniel A. Shoskes, Scott I. Zeitlin & Carol Hart (2002). "Overview summary statement. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)". Urology. 60 (6 Suppl): 1–4. PMID 12521576. Unknown parameter |month= ignored (help)
  8. Waldemar Bialek, Slawomir Rudzki, Pawel Iberszer & Lech Wronecki (2016). "Granulomatous prostatitis after intravesical immunotherapy mimicking prostate cancer". Journal of ultrasonography. 16 (67): 404–410. doi:10.15557/JoU.2016.0040. PMID 28138411. Unknown parameter |month= ignored (help)
  9. Octavio Castillo Cadiz, Lorena Villasenin Parrado, Vincenzo Borgna Christie, Ivan Gallegos Mendez & Virginia Martinez Corta (2016). "Late-onset granulomatous prostatitis following intravesical bacille Calmette-Guerin therapy: case report". Medwave. 16 (5): e6473. PMID 27391977. Unknown parameter |month= ignored (help)
  10. Su-Min Lee, Jay Joshi, Konrad Wolfe, Peter Acher & Sidath H. Liyanage (2016). "Radiologic presentation of chronic granulomatous prostatitis mimicking locally advanced prostate adenocarcinoma". Radiology case reports. 11 (2): 78–82. doi:10.1016/j.radcr.2016.02.009. PMID 27257455. Unknown parameter |month= ignored (help)
  11. Kais Kasem, Kris Kerr, Peter Campbell & Daman Langguth (2016). "IgG4-related prostatitis clinically mimicking prostatic carcinoma: A case report". Pathology. 48 Suppl 1: S71. doi:10.1016/j.pathol.2015.12.185. PMID 27773113. Unknown parameter |month= ignored (help)
  12. Pasquale Urbano & Francesco Urbano (2007). "Nanobacteria: facts or fancies?". PLoS pathogens. 3 (5): e55. doi:10.1371/journal.ppat.0030055. PMID 17530922. Unknown parameter |month= ignored (help)
  13. J. Quentin Clemens, Richard T. Meenan, Maureen C. O'Keeffe Rosetti, Sara Y. Gao & Elizabeth A. Calhoun (2005). "Incidence and clinical characteristics of National Institutes of Health type III prostatitis in the community". The Journal of urology. 174 (6): 2319–2322. doi:10.1097/01.ju.0000182152.28519.e7. PMID 16280832. Unknown parameter |month= ignored (help)

Linked-in.jpg